154 USD
1.43
0.94%
Last update Dec 16, 3:25 PM GMT
Market closed
Day range
152.57001
156.25
Previous close
152.57001
Open
152.57001
Access this stock data via API
Subscribe
Neurocrine Biosciences Inc.
154.00
1.43
0.94%

Statistics

Valuation metrics
Market cap
13.97B
Enterprise value
14.49B
Trailing P/E (ttm)
2.08
Forward P/E
PEG ratio
Price/Sales (ttm)
5.56
Price/Book (mrq)
5.03
Enterprise Value/Revenue
5.40
Enterprise Value/EBITDA
25.42
Overview
Shares outstanding
90.68M
Float
98.54M
Shares short
% Held by insiders
1.02%
% Held by institutions
100.89%
Average volume (10 days)
210
Average volume (90 days)
279
Price summary
52-Week low
84.36
52-Week high
161.05
52-Week change
11.62 13.8%
Beta
0.27
50-Day moving average
135.58
200-Day moving average
114.15
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Dec 31, 2024
Profitability
Profit margin
15.95%
Operating margin
30.10%
Operational effectiveness
Return on assets
8.66%
Return on equity
14.96%
Income statement
Revenue (ttm)
2.68B
Revenue per share (ttm)
26.98
Quarterly revenue growth (yoy)
27.80%
Gross profit (ttm)
1.70B
EBITDA
570M
Net income to common (ttm)
428M
Diluted EPS (ttm)
0.73
Quarterly earnings growth (yoy)
61.40%
Balance sheet
Total cash (mrq)
1.11B
Total cash per share (mrq)
11.18
Total debt (mrq)
479.70M
Total Debt/Equity (mrq)
15.97
Current ratio (mrq)
338.30%
Book value per share (mrq)
30.13
Cash flow
Cash flow statement
636.80M
Levered free cash flow (LFCF)
346.19M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 13 hours 1 minute

18:13
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).